Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: Usefulness of leptin for the treatment of obesity-associated diabetes

Diabetes

Volumn 48, Issue 8, 1999, Pages 1615-1622

  Masuzaki, Hiroaki ^a   Ogawa, Yoshihiro ^a   Aizawa Abe, Megumi ^a   Hosoda, Kiminori ^a   Suga, Junko ^a   Ebihara, Ken ^a   Satoh, Noriko ^a   Iwai, Hidenori ^a   Inoue, Gen ^a   Nishimura, Haruo ^a   Yoshimasa, Yasunao ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALORIC RESTRICTION; DIABETES MELLITUS; GENE MUTATION; GENE OVEREXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL;

AGING; ANIMALS; BODY WEIGHT; DIABETES MELLITUS; EATING; FEMALE; FOOD DEPRIVATION; GLUCOSE; INSULIN; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; MUTATION; OBESITY; PROTEINS;

EID: 0032768291     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.8.1615     Document Type: Article

References (43)

1. Zhang Y, Proenca R, Maffei M, Barone, M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994
2. Pelleymounter MA, Cullen MJ, Bake MBR, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995
3. Halaas JL, Gajiwata KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
4. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995
5. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays CG, Woolf EA, Monroe CA, Tepper RI: Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-1271, 1995
6. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Med 1:1311-1314, 1995
7. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1:1155-1161, 1995
8. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, Mckee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
9. Caro JF, Kolaczynsk JW, Nyce MR, Ohanenesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PI, Sinha MK, Considine RV: Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161, 1996
10. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte DJ: Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med 2:589-593, 1996
11. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A 94:8878-8883, 1997
12. Auwerx J, Staels B: Leptin. Lancet 351:737-742, 1998
13. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ: Acute stimulation of glucose metabolism in mice by leptin treatment, Nature 389:374-377, 1997
14. Cusin I, Zakrzewska KE, Boss O, Muzzin P, Giacobino JP, Ricquier D, Jeanrenaud B, Jeanrenaud FR: Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes 47:1014-1019, 1998
15. Shi ZQ, Nelson A, Whitcomb L, Wang J, Cohen AM: Intracerebroventricular administration of leptin markedly enhances insulin sensitivity and systemic glucose utilization in conscious rats. Metabolism 47:1274-1280, 1998
16. Boston BA, Blaydon KM, Varnerin J, Cone RD: Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278: 1641-1644, 1997
17. Murphy JE, Zhou S, Giese K, Williams LT, Escobedo JA, Dwadki VJ: Long-term correction of obesity and diabetes in genetically obese mice by a single intra-muscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc Natl Acad Sci U S A 94:13921-13926, 1997
18. Ioffe E, Moon B, Connolly E, Friedman JM: Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc Natl Acad Sci U S A 95: 11852-11857, 1998
19. Amatruda JM, Richeson JF, Welle SL, Brodows RG, Lockwood DH: The safety and efficacy of a controlled low-energy (very-low-calorie) diet in the treatment of non-insulin-dependent diabetes and obesity. Arch Intern Med 148:873-877, 1988
20. Campfield LA, Smith FJ, Burn P: Strategies and potential molecular targets for obesity treatment. Science 280:1383-1387, 1998
21. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 382: 250-252, 1996
22. Spiegelman BM, Flier JS: Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389, 1996
23. Ogawa Y, Masuzaki H, Hosoda K, Aizawa-Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N, Odaka H, Kasuga M, Fujisawa Y, Inoue G, Nishimura H, Yoshimasa Y, Nakao K: Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes. In press
24. Leibel RL, Chung WK, Chua SC: The molecular genetics of rodent single gene obesities. J Biol Chem 272:31937-31940, 1997
25. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168, 1997
26. Hoffmann C, Lorenz K, Braitwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM: Altered gene expression for tumor necrosis factor alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
27. Herberg L, Coleman DL: Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 26:59-87, 1997
28. Ogawa Y, Masuzaki H, Isse N, Okazaki T, Mon K, Shigemoto M, Satoh N, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K: Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest 96:1647-1652, 1995
29. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K: Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44:855-858, 1995
30. Erickson JC, Hollopeter G, Palmiter RD: Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:1704-1707, 1996
31. Terauchi Y, Iwamoto K, Tamemoto H, Komeda K, Ishii C, Kanazawa Y, Asanuma N, Aizawa T, Akanuma Y, Yasuda K, Kodama T, Tobe K, Yazaki Y, Kadowaki T: Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and β-cell glucokinase genes: genetic reconstitution of diabetes as apolygenic disease. J Clin Invest 99:861-866, 1997
32. Miller MW, Duhl DMJ, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, Barsh GS: Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Gene Dev 7:454-467, 1993
33. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD: Agouti protein is an antagonist of the melanocyte-stiniulating hormone receptor. Nature 371:799-802, 1994
34. Millar SE, Miller MW, Stevens ME, Barsh GS: Expression and transgenic studies of the mouse agouti gene provide insight into the mechanisms by which mammalian coat color patterns are generated. Development 121:3223-3232, 1995
35. Manne J, Argeson AC, Siracusa LD: Mechanisms for the pleiotropic effects of the agouti gene. Proc Natl Acad Sci U S A 92:4721-4724, 1995
36. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeir LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141, 1997
37. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW: Melanocortin receptors in leptin effects (Letter). Nature 390:349, 1997
38. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K: Satiety effect of and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249:107-110, 1998
39. Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P, Palmiter RD: Response of melanocrtin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nature Genet 21:119-122, 1999
40. Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rossetti L: Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest 99: 2173-2182, 1997
41. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH: Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A 94:4637-4641, 1997
42. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897-901, 1998
43. Chlouverakis C, White PA: Obesity and insulin resistance in the obese-hyperglycemic mouse (ob/ob). Metabolism 18:998-1006, 1969